CGEM
Price
$12.10
Change
-$0.23 (-1.87%)
Updated
Feb 5, 02:34 PM (EDT)
Capitalization
729M
28 days until earnings call
Intraday BUY SELL Signals
STRO
Price
$13.87
Change
-$1.02 (-6.85%)
Updated
Feb 5, 03:37 PM (EDT)
Capitalization
126.85M
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGEM vs STRO

Header iconCGEM vs STRO Comparison
Open Charts CGEM vs STROBanner chart's image
Cullinan Therapeutics
Price$12.10
Change-$0.23 (-1.87%)
Volume$100
Capitalization729M
Sutro Biopharma
Price$13.87
Change-$1.02 (-6.85%)
Volume$100
Capitalization126.85M
CGEM vs STRO Comparison Chart in %
CGEM
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGEM vs. STRO commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a StrongBuy and STRO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CGEM: $12.33 vs. STRO: $14.89)
Brand notoriety: CGEM and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 77% vs. STRO: 80%
Market capitalization -- CGEM: $729M vs. STRO: $126.85M
CGEM [@Biotechnology] is valued at $729M. STRO’s [@Biotechnology] market capitalization is $126.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, CGEM is a better buy in the long-term than STRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 2 bullish TA indicator(s).

  • CGEM’s TA Score: 4 bullish, 4 bearish.
  • STRO’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than STRO.

Price Growth

CGEM (@Biotechnology) experienced а +4.05% price change this week, while STRO (@Biotechnology) price change was -4.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.81%. For the same industry, the average monthly price growth was +0.47%, and the average quarterly price growth was +32.90%.

Reported Earning Dates

CGEM is expected to report earnings on Mar 05, 2026.

STRO is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (-3.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($729M) has a higher market cap than STRO($127M). STRO YTD gains are higher at: 28.695 vs. CGEM (19.130). STRO has higher annual earnings (EBITDA): -166.43M vs. CGEM (-241.13M). CGEM has more cash in the bank: 333M vs. STRO (168M). CGEM has less debt than STRO: CGEM (1.19M) vs STRO (17.7M). STRO has higher revenues than CGEM: STRO (106M) vs CGEM (0).
CGEMSTROCGEM / STRO
Capitalization729M127M574%
EBITDA-241.13M-166.43M145%
Gain YTD19.13028.69567%
P/E RatioN/AN/A-
Revenue0106M-
Total Cash333M168M198%
Total Debt1.19M17.7M7%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMSTRO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signal:
Gain/Loss:
STRO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TVOAX45.540.78
+1.74%
Touchstone Small Cap Value A
RYEAX263.723.85
+1.48%
Rydex Energy H
CBBCX6.870.04
+0.59%
AB Relative Value C
FSKLX13.46N/A
N/A
Fidelity SAI Intl Low Volatil Idx
FEQJX14.97N/A
N/A
Fidelity Advisor Hedged Equity I

CGEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGEM has been closely correlated with ERAS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGEM jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGEM
1D Price
Change %
CGEM100%
-6.66%
ERAS - CGEM
78%
Closely correlated
+6.19%
ATOS - CGEM
78%
Closely correlated
-4.34%
RVMD - CGEM
77%
Closely correlated
+0.56%
STRO - CGEM
77%
Closely correlated
+0.40%
ACET - CGEM
77%
Closely correlated
-3.51%
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been closely correlated with ATOS. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRO jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+0.40%
ATOS - STRO
89%
Closely correlated
-4.34%
CANF - STRO
87%
Closely correlated
-0.25%
PMN - STRO
87%
Closely correlated
-1.57%
PHGE - STRO
87%
Closely correlated
-7.36%
ANL - STRO
81%
Closely correlated
+7.23%
More